{"id":50108,"date":"2022-10-26T17:01:59","date_gmt":"2022-10-26T15:01:59","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\/"},"modified":"2022-10-26T17:01:59","modified_gmt":"2022-10-26T15:01:59","slug":"prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\/","title":{"rendered":"Prenatal Diagnostics Global Market Report 2022: Non-Invasive Prenatal Testing (NIPT) Transforms Prenatal Testing Landscape &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/4721432\/prenatal-diagnostics-global-strategic-business?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=sj4w7p&amp;utm_campaign=1767229+-+Prenatal+Diagnostics+Global+Market+Report+2022%3A+Non-Invasive+Prenatal+Testing+(NIPT)+Transforms+Prenatal+Testing+Landscape&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Prenatal Diagnostics: Global Strategic Business Report&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221026005700\/en\/1614818\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221026005700\/en\/1614818\/21\/logo.jpg\"><\/a><\/p>\n<p>\n<strong>Global Prenatal Diagnostics Market to Reach $9.3 Billion by 2027<\/strong>\n<\/p>\n<p>\nIn the changed post COVID-19 business landscape, the global market for Prenatal Diagnostics, estimated at US$4 Billion in the year 2020, is projected to reach a revised size of US$9.3 Billion by 2027, growing at a CAGR of 12.9% over the analysis period 2020-2027. Non-Invasive, one of the segments analyzed in the report, is projected to record 16% CAGR and reach US$6.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Invasive segment is readjusted to a revised 7.5% CAGR for the next 7-year period.\n<\/p>\n<p>\n<strong>The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 17.2% CAGR<\/strong>\n<\/p>\n<p>\nThe Prenatal Diagnostics market in the U.S. is estimated at US$1.1 Billion in the year 2020. China, the world&#8217;s second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2027 trailing a CAGR of 17.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.7% and 11.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10% CAGR.\n<\/p>\n<p>\n<strong>Select Competitors (Total 43 Featured) &#8211;<\/strong>\n<\/p>\n<ul>\n<li>\nANGLE Plc\n<\/li>\n<li>\nBerry Genomics Co. Ltd.\n<\/li>\n<li>\nBGI Genomics\n<\/li>\n<li>\nF. Hoffmann-La Roche Ltd.\n<\/li>\n<li>\nHologic Inc.\n<\/li>\n<li>\nIllumina Inc.\n<\/li>\n<li>\nLaboratory Corporation of America Holdings\n<\/li>\n<li>\nLifecodexx AG\n<\/li>\n<li>\nNatera Inc.\n<\/li>\n<li>\nQuest Diagnostics Inc.\n<\/li>\n<li>\nRavgen Inc.\n<\/li>\n<li>\nSequenom Inc.\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>I. METHODOLOGY<\/strong>\n<\/p>\n<p>\n<strong>II. EXECUTIVE SUMMARY<\/strong>\n<\/p>\n<p>\n<strong>1. MARKET OVERVIEW<\/strong>\n<\/p>\n<p>\n<strong>2. FOCUS ON SELECT PLAYERS<\/strong>\n<\/p>\n<p>\n<strong>3. MARKET TRENDS &amp; DRIVERS<\/strong>\n<\/p>\n<ul>\n<li>\nNon-Invasive Prenatal Testing (NIPT) Transforms Prenatal Testing Landscape\n<\/li>\n<li>\nMajor Factors Influencing Penetration of NIPT\n<\/li>\n<li>\nNIPT Eliminates Risks &amp; Uncertainty of Conventional Procedures\n<\/li>\n<li>\nReplacing Screening Tests &#8211; A More Conceivable Change through NIPT\n<\/li>\n<li>\nDiversity in NIPT Usage on the Cards\n<\/li>\n<li>\nBenefits Outweigh Snags in NIPT Tests\n<\/li>\n<li>\nWhole Genome Sequencing Technology in NIPT\n<\/li>\n<li>\nDNA &#8211; More Ideal Target for NIPT Analysis than Whole Cells\n<\/li>\n<li>\nConventional Invasive Techniques Loose Sheen\n<\/li>\n<li>\nChromosomal Abnormalities Lead the Prenatal Testing Space\n<\/li>\n<li>\nChromosomal Abnormalities &#8211; A Substantial Economic Burden\n<\/li>\n<li>\nList of Genetic Disorders by Event, Genetic Manifestation and Prevalence\n<\/li>\n<li>\nSignificant Opportunities in Down&#8217;s Syndrome Testing\n<\/li>\n<li>\nList of Select Screening Tests Available for T21 Screening and Confirmation\n<\/li>\n<li>\nBeyond Down&#8217;s Syndrome &#8211; Need to Test Additional Targets Crucial\n<\/li>\n<li>\nACOG and ACGM Recommendations Boost Demand for Prenatal CF Testing\n<\/li>\n<li>\nPrenatal Testing Crucial to Detect Risk of Huntington&#8217;s Disease\n<\/li>\n<li>\nIncreasing Congenital Disorder Incidence &#8211; Key Driver for Prenatal Diagnostics\n<\/li>\n<li>\nPrenatal Testing &#8211; Effective Way of Alleviating Syphilis Related Deaths and Stillbirths\n<\/li>\n<li>\nMolecular Diagnostics Widen Scope &amp; Span of Prenatal Testing\n<\/li>\n<li>\nNGS &amp; MPS &#8211; Enabling Shorter Time to Test Results\n<\/li>\n<li>\nMicroarray-Based Prenatal Testing Gathers Steam\n<\/li>\n<li>\nSequencing in Prenatal Testing &#8211; A Potential High Growth Market\n<\/li>\n<li>\nUltrasound &#8211; An Indispensable Combination with Blood Based Screening Tests\n<\/li>\n<li>\nNew Sub-Targets on the Anvil for Ultrasound-Based Screening\n<\/li>\n<li>\nCounseling &#8211; An Imperative Measure Before and After Prenatal Testing\n<\/li>\n<li>\nRole of Prenatal Testing in Managing Preterm Births\n<\/li>\n<li>\nLower Sensitivity &amp; Specificity of Existing Tests &#8211; A Case for New Tests on the Anvil\n<\/li>\n<li>\nHigh Sensitivity Serum Tests May Not Have Many Takers\n<\/li>\n<li>\nBallooning Global Female Population Offers Increased Growth Opportunities\n<\/li>\n<li>\nIssues &amp; Challenges\n<\/li>\n<li>\nPrenatal Diagnostics: Treading Sensitive Ethical Issues\n<\/li>\n<li>\nControversy Related to &#8220;Incidental Findings&#8221; of Prenatal Tests\n<\/li>\n<li>\nOpposition to NIPT Technique &#8211; A Significant Hurdle to Adoption\n<\/li>\n<li>\nUnresolved Issues Hamper Widespread Testing for Monogenetic Disease\n<\/li>\n<li>\nDearth of Genetic Counselors &#8211; A Major Hurdle for Genetic Testing\n<\/li>\n<\/ul>\n<p>\n<strong>4. GLOBAL MARKET PERSPECTIVE<\/strong>\n<\/p>\n<p>\n<strong>III. MARKET ANALYSIS<\/strong>\n<\/p>\n<p>\n<strong>IV. COMPETITION<\/strong>\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nANGLE Plc\n<\/li>\n<li>\nBerry Genomics Co. Ltd.\n<\/li>\n<li>\nBGI Genomics\n<\/li>\n<li>\nF. Hoffmann-La Roche Ltd.\n<\/li>\n<li>\nHologic Inc.\n<\/li>\n<li>\nIllumina Inc.\n<\/li>\n<li>\nLaboratory Corporation of America Holdings\n<\/li>\n<li>\nLifecodexx AG\n<\/li>\n<li>\nNatera Inc.\n<\/li>\n<li>\nQuest Diagnostics Inc.\n<\/li>\n<li>\nRavgen Inc.\n<\/li>\n<li>\nSequenom Inc.\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/4721432\/prenatal-diagnostics-global-strategic-business?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=sj4w7p&amp;utm_campaign=1767229+-+Prenatal+Diagnostics+Global+Market+Report+2022%3A+Non-Invasive+Prenatal+Testing+(NIPT)+Transforms+Prenatal+Testing+Landscape&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/c0qvsr<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;&#x74;o&#58;&#112;&#x72;&#x65;s&#115;&#64;&#x72;&#x65;se&#97;&#x72;&#x63;&#x68;a&#110;&#x64;&#x6d;&#x61;r&#107;&#101;&#x74;&#x73;&#46;&#99;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#x72;&#101;s&#x73;&#x40;&#114;&#101;s&#x65;&#x61;&#114;&#99;h&#x61;&#x6e;&#100;ma&#x72;&#x6b;&#101;t&#x73;&#x2e;&#99;&#111;m<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Prenatal Diagnostics: Global Strategic Business Report&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Global Prenatal Diagnostics Market to Reach $9.3 Billion by 2027 In the changed post COVID-19 business landscape, the global market for Prenatal Diagnostics, estimated at US$4 Billion in the year 2020, is projected to reach a revised size of US$9.3 &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50108","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Prenatal Diagnostics Global Market Report 2022: Non-Invasive Prenatal Testing (NIPT) Transforms Prenatal Testing Landscape - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prenatal Diagnostics Global Market Report 2022: Non-Invasive Prenatal Testing (NIPT) Transforms Prenatal Testing Landscape - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Prenatal Diagnostics: Global Strategic Business Report&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Global Prenatal Diagnostics Market to Reach $9.3 Billion by 2027 In the changed post COVID-19 business landscape, the global market for Prenatal Diagnostics, estimated at US$4 Billion in the year 2020, is projected to reach a revised size of US$9.3 ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-26T15:01:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221026005700\/en\/1614818\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Prenatal Diagnostics Global Market Report 2022: Non-Invasive Prenatal Testing (NIPT) Transforms Prenatal Testing Landscape &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-10-26T15:01:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\\\/\"},\"wordCount\":695,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221026005700\\\/en\\\/1614818\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\\\/\",\"name\":\"Prenatal Diagnostics Global Market Report 2022: Non-Invasive Prenatal Testing (NIPT) Transforms Prenatal Testing Landscape - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221026005700\\\/en\\\/1614818\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-10-26T15:01:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221026005700\\\/en\\\/1614818\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221026005700\\\/en\\\/1614818\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Prenatal Diagnostics Global Market Report 2022: Non-Invasive Prenatal Testing (NIPT) Transforms Prenatal Testing Landscape &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Prenatal Diagnostics Global Market Report 2022: Non-Invasive Prenatal Testing (NIPT) Transforms Prenatal Testing Landscape - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Prenatal Diagnostics Global Market Report 2022: Non-Invasive Prenatal Testing (NIPT) Transforms Prenatal Testing Landscape - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Prenatal Diagnostics: Global Strategic Business Report&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Global Prenatal Diagnostics Market to Reach $9.3 Billion by 2027 In the changed post COVID-19 business landscape, the global market for Prenatal Diagnostics, estimated at US$4 Billion in the year 2020, is projected to reach a revised size of US$9.3 ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-26T15:01:59+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221026005700\/en\/1614818\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Prenatal Diagnostics Global Market Report 2022: Non-Invasive Prenatal Testing (NIPT) Transforms Prenatal Testing Landscape &#8211; ResearchAndMarkets.com","datePublished":"2022-10-26T15:01:59+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\/"},"wordCount":695,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221026005700\/en\/1614818\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\/","name":"Prenatal Diagnostics Global Market Report 2022: Non-Invasive Prenatal Testing (NIPT) Transforms Prenatal Testing Landscape - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221026005700\/en\/1614818\/21\/logo.jpg","datePublished":"2022-10-26T15:01:59+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221026005700\/en\/1614818\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221026005700\/en\/1614818\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/prenatal-diagnostics-global-market-report-2022-non-invasive-prenatal-testing-nipt-transforms-prenatal-testing-landscape-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Prenatal Diagnostics Global Market Report 2022: Non-Invasive Prenatal Testing (NIPT) Transforms Prenatal Testing Landscape &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50108","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50108"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50108\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50108"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50108"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50108"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}